Stay updated on Current Industry Trends and Future Market Scenario. Our real-time market analysis, and forecasts are for the users that are always on the move. Get instant updates on Healthcare, Technology, Chemicals, and other diverse industry verticals for well-informed business decisions.
Episodes
Wednesday Apr 29, 2015
Wednesday Apr 29, 2015
Global pharmacovigilance market is expected to reach USD 5.51 billion by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of adverse drug reaction and the introduction of stringent drug safety regulations are some key drivers of this market. ADR is responsible for approximately 5% of the hospitalization in developed countries annually, and this is expected to boost usage rates over the next six years. Pharmacovigilance has witnessed a significant rise in usage rates in the recent times owing to growing global geriatric population triggering a growth in demand for new drug development. Additionally, health regulatory authorities such as the U.S. FDA and EMEA (European Medicines Agency) are now emphasizing on electronic submission of data which is also expected to drive the pharmacovigilance market.
Contract outsourcing pharmacovigilance market is expected to grow at a lucrative rate of over 13.1% during the forecast period. Service flexibility and cost effectiveness associated with outsourcing are some key factors accounting for the segment’s lucrative growth.
To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/pharmacovigilance-industry
For more information, visit http://www.grandviewresearch.com/
No comments yet. Be the first to say something!